Upgrades Hold Buy X

JNJ Johnson & Johnson

Erste Group

Downgrades Outperform Mkt Perform X

JNJ Johnson & Johnson

Leerink Partners

$153

Resumed Neutral X

JNJ Johnson & Johnson

BofA Securities

$166

Initiated Outperform X

JNJ Johnson & Johnson

Wolfe Research

$190

Downgrades Outperform Neutral X

JNJ Johnson & Johnson

Daiwa Securities

$160 $150

Resumed Neutral X

JNJ Johnson & Johnson

Goldman

$160

Upgrades Hold Buy X

JNJ Johnson & Johnson

HSBC Securities

$170

Downgrades Overweight Eq Weight X

JNJ Johnson & Johnson

Wells Fargo

$170 $163

Upgrades Neutral Buy X

JNJ Johnson & Johnson

UBS

$167 $180

Initiated Outperform X

JNJ Johnson & Johnson

RBC Capital Mkts

$178

Initiated Hold X

JNJ Johnson & Johnson

HSBC Securities

$175

Resumed Buy X

JNJ Johnson & Johnson

Citigroup

$185

Initiated Neutral X

JNJ Johnson & Johnson

UBS

$164

Initiated Neutral X

JNJ Johnson & Johnson

Guggenheim

$161

Initiated Neutral X

JNJ Johnson & Johnson

Credit Suisse

$170

Initiated Equal Weight X

JNJ Johnson & Johnson

Barclays

$175

Reiterated Neutral X

JNJ Johnson & Johnson

BofA Securities

$185 $178

Initiated Outperform X

JNJ Johnson & Johnson

Daiwa Securities

Resumed Outperform X

JNJ Johnson & Johnson

SVB Leerink

$200

Downgrades Outperform Mkt Perform X

JNJ Johnson & Johnson

Bernstein

$180 $183

Initiated Neutral X

JNJ Johnson & Johnson

Goldman

$161

Reiterated Buy X

JNJ Johnson & Johnson

Citigroup

$192 $195

Resumed Overweight X

JNJ Johnson & Johnson

Morgan Stanley

$187

Resumed Outperform X

JNJ Johnson & Johnson

Credit Suisse

$156

Initiated Buy X

JNJ Johnson & Johnson

Goldman

Upgrades Sell Neutral X

JNJ Johnson & Johnson

Goldman

Initiated Mkt Perform X

JNJ Johnson & Johnson

Bernstein

$129

Reiterated Neutral X

JNJ Johnson & Johnson

Citigroup

$146 $134

Reiterated Hold X

JNJ Johnson & Johnson

Stifel

$145 $135

JNJ  Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.